Deferred Tax Assets, Valuation Allowance of BioCorRx Inc. from 31 Dec 2012 to 31 Dec 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.
Summary
BioCorRx Inc. quarterly Deferred Tax Assets, Valuation Allowance in USD history and change rate from 31 Dec 2012 to 31 Dec 2024.
  • BioCorRx Inc. Deferred Tax Assets, Valuation Allowance for the quarter ending 31 Dec 2024 was $12,347,394, a 10% increase year-over-year.
Source SEC data
View on sec.gov
Deferred Tax Assets, Valuation Allowance, Quarterly (USD)
Deferred Tax Assets, Valuation Allowance, YoY Quarterly Change (%)

BioCorRx Inc. Quarterly Deferred Tax Assets, Valuation Allowance (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q4 2024 $12,347,394 +$1,119,473 +10% 31 Dec 2024 10-K 31 Mar 2025 2024 FY
Q4 2023 $11,227,921 +$891,169 +8.6% 31 Dec 2023 10-K 31 Mar 2025 2024 FY
Q4 2022 $10,336,752 +$973,015 +10% 31 Dec 2022 10-K 01 Apr 2024 2023 FY
Q4 2021 $9,363,737 +$2,708,847 +41% 31 Dec 2021 10-K 31 Mar 2023 2022 FY
Q4 2020 $6,654,890 +$12,329,972 31 Dec 2020 10-K 31 Mar 2022 2021 FY
Q4 2019 $5,675,082 -$1,688,457 -42% 31 Dec 2019 10-K 31 Mar 2021 2020 FY
Q4 2018 $3,986,625 -$7,084,627 -229% 31 Dec 2018 10-K 30 Mar 2020 2019 FY
Q4 2017 $3,098,002 +$1,151,668 +59% 31 Dec 2017 10-K 16 Apr 2019 2018 FY
Q4 2016 $1,946,334 -$20,583 -1% 31 Dec 2016 10-K 05 Apr 2018 2017 FY
Q4 2015 $1,966,917 -$554,644 -22% 31 Dec 2015 10-K 13 Apr 2017 2016 FY
Q4 2014 $2,521,561 +$4,290,283 31 Dec 2014 10-K 14 Apr 2016 2015 FY
Q4 2013 $1,768,722 -$1,104,402 -166% 31 Dec 2013 10-K 31 Mar 2015 2014 FY
Q4 2012 $664,320 31 Dec 2012 10-K 14 Apr 2014 2013 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.